Ashvini Keshavan
@AshviniKeshavan
Neurologist, Early Career Researcher in Dementia, Ageing & Fluid Biomarkers @UCL, Odissi dancer. Views expressed are my own.
It was great to be able to update on plans for the ADAPT study on @BBCRadio4 and thanks @SelinaWray for hosting in your lab and sharing the amazing work you are doing with organoids to elucidate disease mechanisms and allow for screening of therapeutic targets!
Great to see @AshviniKeshavan on @BBCRadio4's Inside Health show today, discussing what's next for dementia research following the NICE decisions on lecanemab and donanemab. Listen here 👇bbc.co.uk/programmes/m00…
Great experience to facilitate and author this paper with @NicholasAshton @wagnersbrum @jmschott Henrik Zetterberg - unprecedented level of industry and academic collaboration showing p-tau217 has highest fold change in symptomatic AD over non-AD participants from @drcionucl
🚨 Available as a preprint – The @alzassociation #pTau round robin study 🚨 📣 33 different ways to measure #blood #pTau 📣 Mass Spec, semi & fully-auto immunoassays 📣 #pTau217 consistently best 📣 Corr. between assays = optimism for standardisation medrxiv.org/content/10.110…
The collection of #blood #biomarkers studies using NULISA as presented at day two of #AAIC2024 is now available as a pre-print 🩸🧪🧠 medrxiv.org/content/10.110… @andrealessa @M_SuarezCalvet @Alamarbio @jmschott @BarbaraBorroni7 @alessandro5161 @goteborgsuni @BarcelonaBeta
Post-Doctoral Research Fellow to work at the MRC Prion Unit at UCL on multiplexed seed amplification assays in mixed dementia, and improving sensitivity. Please take a look and email me if you have any questions or would like to look around the labs. ucl.ac.uk/work-at-ucl/se…
Looking forward to this opportunity to discuss blood tests for Alzheimer’s, answer questions from the public, and speak about the ADAPT study - all welcome, register to join at 13:00 UK time today!
What does the future of diagnosing dementia look like? Could blood tests revolutionise the process, making it quicker & easier? Join our scientists Dr Maura Malpetti & Dr Ashvini Keshavan as they delve into these important questions & more. Sign up now! alzheimersresearchuk.org/research/onlin…
Do apply to work with this great team on the innovative DIADEM study looking at both digital auditory and blood biomarkers in real world memory clinics, headed by @charl_marshall & Chris Hardy at UCL.
QMUL @preventiveneur1 seek a Research Assistant to evaluate the utility of digital auditory biomarkers to support the diagnosis of Alzheimer’s and stratification of patients with mild cognitive disorder in NHS memory clinics. Closing date: 10th June dementiaresearcher.nihr.ac.uk/job/research-a…
Thanks for the interview; privileged to lead the ADAPT study with @jmschott @ucl - buzzing from our first in person steering group meeting with protocol drafting, patient/public engagement, staff recruitment and collaboration with @imperialcollege @LSEnews @UniKent all underway!
Dr @AshviniKeshavan @drcionucl will co-lead the Blood Biomarker Challenge, which aims to revolutionise dementia diagnosis. Read the interview ➡️ bit.ly/4dtbVR3 #DementiaActionWeek #DAW2024 #UCLDementia
Academic clinical lecturer post in #Neurology @ImperialBrains with a focus on #Dementia & opportunities to work with colleagues across @imperialcollege and 2 @UKDRI Centres. Please RT and do get in touch if interested! oriel.nhs.uk/Web/Vacancy/Va…
Thanks @AsianVoiceNews for the coverage of the role that the Blood Biomarker challenge grant award will play in bringing accurate dementia diagnosis to local communities in the UK, and for featuring the ADAPT study. asian-voice.com/News/UK/HOPE-F… @ARUKscientist @alzheimerssoc
Indian-origin neurologist @AshviniKeshavan's UK study to revolutionise dementia diagnosis #Neurology #dementia #Alzheimers #healthcare newsdrum.in/international/…
A world-class research team @uclh and @UCLIoN led by @jmschott & @AshviniKeshavan has been awarded £3.76m to carry out a nationwide trial to identify accurate and quick blood tests that can diagnose dementia. uclhospitals.brc.nihr.ac.uk/news/blood-tes… @alzheimerssoc @AlzResearchUK @NIHRresearch
Honoured to be co-leading the ADAPT study of plasma p-tau217 in the UK with @jmschott, bringing together expertise from @ucl in dementia research @drcionucl, nationally accredited lab @uclh, patient&public engagement @UniKent, cost-effectiveness @LSEnews
Great to announce that teams @UCLIoN and @DementiasUK have both been awarded the Blood Biomarker Challenge. The @ucl team will test the diagnostic utility of ptau217 for Alzheimer’s in @NHS memory clinics @alzheimerssoc @AlzResearchUK @NIHRresearch @BBCr4today @UKDRI